Laddar...
Radiolabeled antibodies in renal cell carcinoma
Renal cell carcinoma (RCC) is a radio- and chemotherapy resistant tumor, which has a very high morbidity and mortality when metastasized. The current treatment options demonstrate limited efficacy and severe side-effects. Therefore, there is a need for new therapeutic strategies for RCC. As for othe...
Sparad:
| Huvudupphovsmän: | , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
e-Med
2007
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2151324/ https://ncbi.nlm.nih.gov/pubmed/18055291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1102/1470-7330.2007.0025 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|